The same GLP-1 medications reshaping weight loss have been linked to lower rates of depression and anxiety, adding to a ...

As the psychedelic drug industry shifts from a speculative niche to a potential part of mainstream healthcare, investors have ...

Considering they’re a class of drugs known for making you smaller, GLP-1 receptor agonists are only getting bigger. As many ...

In addition to her husband and family members on both sides, Lindsay Clancy is asking a judge to agree to allow her to call ...

After years spent searching for remedies, Polyendocrine Metabolic Ovarian Syndrome (PMOS) sufferer Chloe Morgan was recently ...

In addition to her husband and family members on both sides, Lindsay Clancy is expected to call witnesses from her ...

Common medications that a lot of people take daily can seriously increase your risk of heat-related illness. The post Are you ...

An in-depth look at the leading psychedelic stocks in the U.S. stock market this year. Here's what you need to know.

In a private meeting, HHS officials met with mental health professionals to work on guidance for stopping SSRIs.

In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...

Adults with major depressive disorder experienced statistically significant and clinically meaningful improvements with a ...